Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-067725
Filing Date
2017-11-13
Accepted
2017-11-13 09:01:25
Documents
50
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20617_110q.htm 10-Q 1080293
2 EX-10.1 a17-20617_1ex10d1.htm EX-10.1 13380
3 EX-31.1 a17-20617_1ex31d1.htm EX-31.1 12101
4 EX-31.2 a17-20617_1ex31d2.htm EX-31.2 12440
5 EX-32.1 a17-20617_1ex32d1.htm EX-32.1 8011
12 GRAPHIC g206171koi001.gif GRAPHIC 3967
  Complete submission text file 0001104659-17-067725.txt   3891830

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stdy-20170930.xml EX-101.INS 666113
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stdy-20170930.xsd EX-101.SCH 33780
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stdy-20170930_cal.xml EX-101.CAL 33679
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stdy-20170930_def.xml EX-101.DEF 136567
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stdy-20170930_lab.xml EX-101.LAB 340740
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stdy-20170930_pre.xml EX-101.PRE 241435
Mailing Address 5 OPPENHEIMER STREET REHOVOT L3 76701
Business Address 5 OPPENHEIMER STREET REHOVOT L3 76701 (925) 272-4991
SteadyMed Ltd. (Filer) CIK: 0001619087 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36889 | Film No.: 171193444
SIC: 2834 Pharmaceutical Preparations